Category: Consultants’ blog

UroLift for BPH and other new horizons for treatment of benign prostatic enlargement

By Maya Harris, consultant urologist BPC Traditionally, only TURP with its significant side-effects was available for men who suffer from symptoms caused by benign prostatic hyperplasia (BPH).  GreenLight Laser prostatectomy, introduced by the Birmingham Prostate Clinic in 2007, was the first minimally-invasive option for BPH.  Recently, more procedures have appeared on horizon. I am a […]

Read more

Advice for women considering vaginal slings and our position on concerns about TVT mesh implants

By Mohammed Belal, consultant urologist specialising in bladder conditions, BPC The use of vaginal slings is a long-established approach for treating stress incontinence in women. The principle is simple: the sling is fitted like a ‘hammock’ under the urethra to provide support. When there is pressure, such as during a cough, sneeze or exercise, the […]

Read more

We have carried out MRI scans before biopsy for the past four years. Now a major study shows this is twice as effective in identifying prostate cancer and should be adopted as standard practice in the UK

By Alan Doherty, consultant urologist, BPC It has been hailed as a game changer which is the biggest leap forward in prostate cancer diagnosis for decades. Such is the significance of the major trial, published today in The Lancet ,  which shows a multi-parametric MRI scan is twice as accurate in prostate cancer detection, compared […]

Read more

No more false dawns: how fusion biopsies and new diagnostic pathways are ending the uncertainty of ‘false negatives’

The most significant developments in my field recently have not been in how we treat prostate cancer, but what we do beforehand, to assess and understand the disease. Six years ago, like all UK urologists, the prostate biopsy I commonly used was the TRUS (transrectal ultrasound-guided biopsy). It involves inserting 12 needles through the rectum […]

Read more

MRI before biopsy for prostate cancer: agreed. But which technology? BPC surgeon Alan Doherty reflects on key developments at the annual conference for urologists.

By Alan Doherty, consultant urologist and founder of the Birmingham Prostate Clinic The annual meeting of the British Association of Urological Surgeons always provides a valuable bellwether for key developments in prostate cancer. I attended this year’s meeting in Liverpool at the end of June and one theme particularly stood out: the use of MRI […]

Read more

BPC surgeon Paul Anderson describes his work in Zambia: treating urethral strictures and building a future service

For a surgeon accustomed to recently built West Midlands hospitals, it was inevitably going to be a dramatically different place for the morning ward round. “I remember seeing patients on mattresses crammed into every available space,” Paul Anderson recalls of his first day in Lusaka, Zambia, southern Africa. “My main memory from that first morning […]

Read more

Keith Padbury’s experience of the PCA3 test, a new genetics based assessment of prostate cancer risk

Keith Padbury was one of the first patients to have a PCA3 test, a new genetics based assessment of prostate cancer risk five years ago. He has benefitted from advanced assessments which mean unnecessary biopsies are avoided. Keith describes his own experience and how an elevated PSA result does not inevitably lead to a biopsy […]

Read more